Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A RETROSPECTIVE ANALYSIS OF THE EFFICACY AND TOLERABILITY OF LACOSAMIDE IN PATIENTS WITH BRAIN TUMOR

Autor: Saria, Marlon G, Corle, Courtney, Hu, Jethro, Rudnick, Jeremy, Phuphanich, Surasak, Mrugala, Maciej M, Lee, Laura K, Fu, Beverly D, Bota, Daniela A, Kim, Ryan Y, Brown, Tiffany, Feely, Homira, Hu, Alexander, Drappatz, Jan, Wen, Patrick Y, Lee, Jong W, Carter, Bob, Kesari, Santosh

Publikováno v: Saria, Marlon G; Corle, Courtney; Hu, Jethro; Rudnick, Jeremy; Phuphanich, Surasak; Mrugala, Maciej M; et al.(2011). A RETROSPECTIVE ANALYSIS OF THE EFFICACY AND TOLERABILITY OF LACOSAMIDE IN PATIENTS WITH BRAIN TUMOR. NEURO-ONCOLOGY, 13, 49-49. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/798159h9

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::fc07647587dab43245612ca478e42fc3
http://www.escholarship.org/uc/item/798159h9

Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+T-lymphocyte counts

Autor: Bota, Daniela A, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A, Kong, Xiao-Tang, Fu, Beverly D, Hsu, Frank PK, Schönthal, Axel H, Hofman, Florence M, Chen, Thomas C, Zidovetzki, Raphael, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil EJC, Stathopoulos, Apostolos

Publikováno v: CNS Oncology; July 2018, Vol. 7 Issue: 3

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 ⁺ T-lymphocyte counts.

Autor: Bota DA; Department of Neurology, University of California Irvine, Irvine, CA 92868, USA.; Department of Neurological Surgery, University of California Irvine, Irvine, CA 92868, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA 92868, USA., Chung J; Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA 92868, USA., Dandekar M; Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA 92868, USA., Carrillo JA; Department of Neurology, University of California Irvine, Irvine, CA 92868, USA.; Department of Neurological Surgery, University of California Irvine, Irvine, CA 92868, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA 92868, USA., Kong XT; Department of Neurology, University of California Irvine, Irvine, CA 92868, USA.; Department of Neurological Surgery, University of California Irvine, Irvine, CA 92868, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA 92868, USA., Fu BD; Department of Neurology, University of California Irvine, Irvine, CA 92868, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA 92868, USA., Hsu FP; Department of Neurological Surgery, University of California Irvine, Irvine, CA 92868, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA 92868, USA., Schönthal AH; Department of Molecular Microbiology & Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA., Hofman FM; Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA., Chen TC; Department of Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA., Zidovetzki R; Cell Biology & Neuroscience, University of California, Riverside, CA 92507, USA., Pretto C; Epitopoietic Research Corporation, Gembloux, 5032 Isnes, Belgium., Strik A; Department of Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.; Epitopoietic Research Corporation, Gembloux, 5032 Isnes, Belgium., Schijns VE; Epitopoietic Research Corporation, Gembloux, 5032 Isnes, Belgium.; Cell Biology & Immunology Group, Wageningen University, 6708 Wageningen, The Netherlands., Stathopoulos A; Epitopoietic Research Corporation, Gembloux, 5032 Isnes, Belgium.; Cell Biology & Immunology Group, Wageningen University, 6708 Wageningen, The Netherlands.; Department of Neurosurgery, Euroclinics Hospital, 151 21 Athens, Greece.

Publikováno v: CNS oncology [CNS Oncol] 2018 Jul 01; Vol. 7 (3), pp. CNS22. Date of Electronic Publication: 2018 Aug 29.